Skip to main content
Wolfson Institute of Population Health
  1. WIPH
  2. People
  3. Profiles

Mr Panos Alexandris, MSc

Panos

Statistician / PhD student

Email: p.alexandris@qmul.ac.uk
Telephone: 020 7882 3306
Room Number: G011, Wolfson Institute

Profile

I joined QMUL in 2020 to work as a Trial Statistician for the Yorkshire Lung Screening Trial. Prior to that, I did my BSc in Mathematics and MSc in Biostatistics at the University of Athens, Greece.

Currently I work at the Centre for Prevention, Detection and Diagnosis, where I’m doing a PhD on ‘Risk factors for lung cancer in individuals with screen-detected lung nodules’ under the supervision of Prof. Stephen Duffy, Dr Samantha Quaife, and Prof. Rhian Gabe. I am also involved in other trials and observational studies on cancer screening.

Research

Research Interests:

Biostatistics

Cancer Screening

Lung Cancer Screening 

Publications

  • Alexandris P, Quaife S, Berg CD et al. (2025). Protocol for a systematic review and individual participant data meta-analysis for risk factors for lung cancer in individuals with lung nodules identified by low-dose CT screening. nameOfConference


  • Hamad W, Grigore B, Walford H et al. (2025). Biomarkers suitable for early detection of intrathoracic cancers in primary care: a systematic review.. nameOfConference


  • Murray RL, Alexandris P, Baldwin D et al. (2024). Uptake and 4-week quit rates from an opt-out co-located smoking cessation service delivered alongside community-based low-dose computed tomography screening within the Yorkshire Lung Screening Trial. nameOfConference


  • Bradley C, Alexandris P, Baldwin DR et al. (2023). Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD. nameOfConference


  • Bailey H, Alexandris P, Bradley C et al. (2023). 154 The impact of reminder invitations on participation in community-based lung cancer screening. nameOfConference


  • Murray R, Brain K, Britton J et al. (2022). PL03.03 Personalised Smoking Cessation Support in a Lung Cancer Screening Programme: The Yorkshire Enhanced Stop Smoking Study (YESS). nameOfConference


  • Murray R, Brain K, Britton J et al. (2022). Personalised Smoking Cessation Support in a Lung Cancer Screening Programme: The Yorkshire Enhanced Stop Smoking Study (YESS). 2022 World Conference on Lung Cancer


  • Crosbie PAJ, Gabe R, Simmonds I et al. (2022). Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial. nameOfConference


  • Dinneen E, Shaw GL, Kealy R et al. (2022). Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing. nameOfConference


  • Bradley C, Kennedy M, Boland A et al. (2021). Spirometry and under-diagnosis of COPD in a lung cancer screening cohort. Lung cancer


View profile publication page
Back to top